Old West Investment Management’s Fulgent Genetics FLGT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-81,338
Closed -$2.35M 54
2023
Q4
$2.35M Sell
81,338
-3
-0% -$80 1.21% 25
2023
Q3
$2.18M Buy
81,341
+68
+0.1% +$2.32K 1.1% 25
2023
Q2
$3.01M Buy
81,273
+462
+0.6% +$16.1K 1.58% 19
2023
Q1
$2.52M Sell
80,811
-10,658
-12% -$343K 1.36% 20
2022
Q4
$2.72M Buy
91,469
+1,676
+2% +$60K 1.7% 17
2022
Q3
$3.42M Sell
89,793
-12,694
-12% -$636K 2.42% 14
2022
Q2
$5.59M Buy
102,487
+1,938
+2% +$107K 3.91% 9
2022
Q1
$6.28M Buy
100,549
+45,048
+81% +$2.97M 3.37% 12
2021
Q4
$5.58M Buy
55,501
+661
+1% +$58.1K 2.74% 11
2021
Q3
$4.93M Buy
54,840
+13,231
+32% +$1.2M 1.29% 18
2021
Q2
$3.84M Buy
41,609
+1,673
+4% +$134K 0.79% 23
2021
Q1
$3.86M Sell
39,936
-120,956
-75% -$12.5M 0.81% 23
2020
Q4
$8.38M Sell
160,892
-25,199
-14% -$1.05M 1.9% 13
2020
Q3
$7.45M Sell
186,091
-105,369
-36% -$3.3M 1.72% 11
2020
Q2
$4.66M Sell
291,460
-49,833
-15% -$763K 1.38% 14
2020
Q1
$3.67M Sell
341,293
-187,116
-35% -$2.61M 2.76% 11
2019
Q4
$6.82M Sell
528,409
-28,884
-5% -$343K 2.51% 8
2019
Q3
$5.79M Buy
557,293
+109,348
+24% +$1.04M 3.4% 8
2019
Q2
$2.99M Buy
447,945
+404
+0.1% +$2.46K 1.41% 17
2019
Q1
$2.66M Buy
447,541
+13,087
+3% +$60K 0.96% 25
2018
Q4
$1.38M Buy
434,454
+34,140
+9% +$120K 0.37% 36
2018
Q3
$1.57M Buy
400,314
+45,558
+13% +$195K 0.65% 42
2018
Q2
$1.47M Buy
354,756
+6,515
+2% +$25.8K 0.74% 42
2018
Q1
$1.39M Buy
348,241
+135,263
+64% +$596K 0.8% 42
2017
Q4
$932K Buy
+212,978
New +$816K 0.53% 50

Other funds holding FLGT

Old West Investment Management's FLGT Position: Q1 2024 in Review

Old West Investment Management sold out of Fulgent Genetics (FLGT) in Q1 2024, closing a stake of 81,338 shares — an estimated $2.35M sold.

Old West Investment Management first reported a position in FLGT in Q4 2017 and held it in 25 quarters. The position peaked at $8.38M in Q4 2020. 180 funds tracked by Wall St. Rank hold FLGT as of Q1 2024.

  • Old West Investment Management reported no remaining Fulgent Genetics position as of Q1 2024 after selling out during the quarter.
  • Old West Investment Management sold 81,338 Fulgent Genetics shares in Q1 2024, an estimated $2.35M.
  • Old West Investment Management first reported a position in Fulgent Genetics in Q4 2017 and held it in 25 quarters.
  • Old West Investment Management's Fulgent Genetics position peaked at $8.38M in Q4 2020.
  • 180 funds tracked by Wall St. Rank held Fulgent Genetics as of Q1 2024.

Based on Old West Investment Management's 13F filing for Q1 2024, filed 8 May 2024.